Researchers have identified a surprising metabolic effect of a widely used diabetes drug in men undergoing prostate cancer treatment.
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects ...
A common diabetes drug may mimic one key effect of exercise in prostate cancer patients. Researchers found metformin boosts an “exercise molecule” linked to appetite and weight control, even in those ...
Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment ...
A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome ...
A COMMON drug already given to millions of Brits could mimic the effects of “intense” exercise in people who can’t work out, ...
A study in older women indicates that combining exercise with hormone treatment can reduce visceral fat without affecting overall weight.
Impact of CYP2D6 polymorphisms on adverse events in patients with breast cancer treated with tamoxifen: Insights from an early dose escalation trial in CYP2D6 poor metabolizers. Impact of circulating ...
DENVER — Postmenopausal women who receive hormone therapy show significantly greater weight loss when treated with the glucagon-like peptide 1 (GLP-1) receptor agonist drug semaglutide than those who ...
CINCINNATI (WKRC) — Just in time for Father's Day, men looking to boost their testosterone levels might consider some lifestyle changes beyond traditional injections. Katie Vincent, a nurse ...
Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results